Welcome to LookChem.com Sign In|Join Free
  • or
Ethyl 2-guanidino-4-methylthiazole-5-carboxylate is a chemical compound with the molecular formula C7H12N4O2S. It is a white crystalline solid that is soluble in water and various organic solvents. ethyl 2-guanidino-4-methylthiazole-5-carboxylate is primarily used as a pharmaceutical intermediate, specifically in the synthesis of drugs targeting the central nervous system. Its structure features a thiazole ring with a guanidine group at the 2-position and a methyl group at the 4-position, with a carboxylate group attached to the 5-position and an ethyl ester group at the 1-position. The compound's unique structure and properties make it a valuable building block in the development of new therapeutic agents, particularly those with potential applications in the treatment of neurological disorders and pain management.

7185-65-1

Post Buying Request

7185-65-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

7185-65-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 7185-65-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,1,8 and 5 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 7185-65:
(6*7)+(5*1)+(4*8)+(3*5)+(2*6)+(1*5)=111
111 % 10 = 1
So 7185-65-1 is a valid CAS Registry Number.

7185-65-1Relevant academic research and scientific papers

Synthesis of Substituted Aminopyrimidines as Novel Promising Tyrosine Kinase Inhibitors

Stolpovskaya,Kruzhilin,Zorina,Shikhaliev, Kh. S.,Ledeneva,Kosheleva,Vandyshev, D. Yu.

, p. 1322 - 1328 (2019)

A procedure has been proposed for the synthesis of a series of substituted N-(1,3-thiazol-2-yl)-pyrimidin-2-amines and N-(pyrimidin-2-yl)thioureas by reactions of diethyl 2-(ethoxymethylidene)malonate and ethyl 2-(ethyoxymethylidene)-3-oxobutanoate with 1

Method for synthesizing 2-guanidinothiazole compound by one-pot process

-

Paragraph 0014, (2020/11/09)

According to the invention, a substituted methyl ketone compound is innovatively used as a raw material, amidinothiourea is added into an alcohol solvent under the conditions of halogeno salt MX and Oxone, and a one-pot process one-step reaction is carried out to obtain the target 2-guanidinothiazole compound. Common methyl ketone is used for replacing an alpha-halogenated carbonyl compound whichis high in price and toxicity, MX which is low in price and easy to obtain is used as a halogen source, the method is novel, raw materials and reagents are cheap, reaction conditions are mild, and operation is easy and convenient, therefore low-cost, convenient and rapid synthesis of the 2-guanidinothiazole compound is achieved.

Identification of potent pyrimidine inhibitors of phosphodiesterase 7 (PDE7) and their ability to inhibit T cell proliferation

Guo, Junqing,Watson, Andrew,Kempson, James,Carlsen, Marianne,Barbosa, Joseph,Stebbins, Karen,Lee, Deborah,Dodd, John,Nadler, Steven G.,McKinnon, Murray,Barrish, Joel,Pitts, William J.

scheme or table, p. 1935 - 1938 (2009/11/30)

A series of pyrimidine based inhibitors of PDE7 are discussed. The synthesis, structure-activity relationships (SAR) and selectivity against several other PDE family members as well as activity in T cells are presented. These compounds were found to have effects on T cell proliferation, however it is not clear whether the mechanism is related to PDE7 inhibition.

Three-component synthesis of 4-aryl-5-cyano-2-hetarylaminopyrimidines

Shikhaliev,Kryl'skaya,Potapov

, p. 1089 - 1090 (2008/02/01)

Three-component condensation of benzooxazol-2-yl-, benzothiazol-2-yl-, and 5-ethoxycarbonyl-4-methyl-1,3-thiazol-2-ylguanidines with orthoesters and aroylacetonitriles afforded 4-aryl-5-cyano-2-hetarylaminopyrimidines.

Fused pyrimidine based inhibitors of phosphodiesterase 7 (PDE7): Synthesis and initial structure-activity relationships

Kempson, James,Pitts, William J.,Barbosa, Joseph,Guo, Junqing,Omotoso, Omonike,Watson, Andrew,Stebbins, Karen,Starling, Gary C.,Dodd, John H.,Barrish, Joel C.,Felix, Raymond,Fischer, Karl

, p. 1829 - 1833 (2007/10/03)

A series of fused pyrimidine based inhibitors of PDE7 have been derived from an earlier screening lead 1. The synthesis, structure-activity relationships (SAR) and selectivity against several other PDE family members are described.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 7185-65-1